Source: Clinical Breast Cancer. Unidade: FM
Subjects: SEGUIMENTOS, NEOPLASIAS MAMÁRIAS, METÁSTASE NEOPLÁSICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GÓMEZ, Henry L. et al. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer, v. 16, n. 1, p. 38-44, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.clbc.2015.10.005. Acesso em: 07 nov. 2024.APA
Gómez, H. L., Neciosup, S., Tosello, C., Mano, M., Bines, J., Ismael, G., et al. (2016). A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer, 16( 1), 38-44. doi:10.1016/j.clbc.2015.10.005NLM
Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) [Internet]. Clinical Breast Cancer. 2016 ; 16( 1): 38-44.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.clbc.2015.10.005Vancouver
Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) [Internet]. Clinical Breast Cancer. 2016 ; 16( 1): 38-44.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.clbc.2015.10.005